From transfer to treatment: Bridging social policy and drug use therapy
As substance use disorders continue to make significant contributions to global morbidity and mortality, innovative financial strategies have become a powerful leverage to bridge the gap between social determinants between health and clinical outcomes. Conditional cash transfer (CCT) programs represent such a strategy to provide monetary assistance to low-income families on the condition that funds are used for social services such as health care, education and nutrition. Not only do these programs alleviate immediate financial difficulties, but they also create pathways for improving long-term health outcomes, as studies show their effectiveness in reducing child mortality and improving nutrition.
Recently, a study was published that evaluated the novel impacts these procedures could exert in addressing substance use, making it one of the few studies evaluating this association. Dr. Lidiane Toledo and her team conducted a population-based study in Brazil to investigate the implementation of CCT in Brazil Bolsa Familia (BFP), related to hospitalization treatment for drug use disorders (SUD). They found that between 2008 and 2015, using the Poisson regression model recorded by the connected hospital and BFP program, they found that BFP enrollment was associated with a 16.89% reduction in SUD-related hospitalizations, which was particularly evident in municipalities whose Brazilian deprivation index was classified as lower socioeconomic status.
Supporting these findings, the evidence in Mexico further enhances the broader relevance of the CCT program in addressing SUD. Mexico's CCT program, Oportunidadesis one of the world's earliest CCT programs, aiming to provide residents with similar benefits as Bolsa Familia. An assessment of the program in 2007 found that a wife’s salary of 200 pesos increased significantly reduced the likelihood of husbands being consumed by 15%. Like bfp Oportunidades Initially designed to increase access to social services, such as health, nutrition or schooling. However, by creating home-level incentives, these programs affect behavior outside of direct recipients. The impact of policy is obvious: CCT may provide scalable upstream interventions to reduce substance-related harm, especially in low- and middle-income countries (LMICs) with formal treatment services.
Despite this, while CCTS shows great hope, economic incentives alone are not a panacea. To maximize its impact, these programs should be combined with further efforts to enhance the medical infrastructure for drug use treatment worldwide. For example, in the field of obtaining behavioral health or addiction experts, training non-physics experts can significantly improve the availability of services. This can include social workers and community health workers, especially since they are often more deeply involved in their communities and can better provide culturally relevant care and support.
In addition, integrating SUD care into primary care access for existing CCT connections such as BFP and Oportunidades – Will increase intake and continuity. Specifically, these integration efforts could help reduce stigma surrounding substance use, as it will standardize SUD care under a wider healthcare infrastructure. Telehealth services can also provide a complementary strategy to expand care that is geographically remotely set. By leveraging telemedicine platforms, clinicians can provide remote appointments, monitoring and follow-up access, which helps overcome some of the logistical barriers imposed through physical distance and limited infrastructure.
CCTs are not alternatives to alternative therapeutic infrastructure, but when strategically integrated, they can be used as an effective, stock-oriented platform for SUD prevention and care. This evolving model challenges us to rethink our prevention and treatment approaches. Instead of treating these conditions as isolated clinical issues, we must consider a broader social and structural context, we recognize that poverty, social deprivation, and economic instability are not only relevant factors, but also necessary considerations for the development of effective, equitable interventions. Given the widespread prevalence of SUDs worldwide, this public health intervention is critical to reducing health disparities and promoting overall rehabilitation.
Photo: Stock Finland, Getty Images
Suhanee Mitragotri is an undergraduate at Harvard University, a middle school that studies neuroscience, which is global health and wellness policy. She is also the co-founder of the Naloxone Education Program, which aims to expand opioid and naloxone education to youth. She has written about topics related to the opioid crisis, harm reduction and drug policy and has published articles in a variety of journals and magazines, including the Lancet Regional Health America, Addiction, Frontiers in Health Affairs, The Boston Globe and New Scientist.
David T. His research focuses on drug use disorders, clinical epidemiology, health economics, and social determinants of health. His work has been published in major journals including the Lancet, the Lancet Regional Health America, Jama Network Open, Jama Psychiatry, Natural Science Reporting and the Journal of Injury Reduction. David’s contribution to addressing the overdose crisis has been recognized by several foundations, including the Diana Award, the Boston Public Health Conference under 40 Public Health Under 40, the National Forum on the Quality of Minority Under 40, and the U.S. Public Health Award for Excellence in Public Health.
This article passed Mixed Influencer program. Anyone can post a view on MedCity News' healthcare business and innovation through MedCity Remacence. Click here to learn how.
